The drug approval process involves several stages. It starts with preclinical studies, followed by clinical trials that assess the drug in humans. Regulatory bodies evaluate the data from these trials to determine if the drug should be approved. The process includes several phases, each increasing in scale and scope, to gather comprehensive safety and efficacy data. The review process can be expedited for drugs that address unmet medical needs or offer significant benefits over existing treatments.
